Literature DB >> 8043359

An institutional experience with arterial atheroembolism.

D S Baumann1, D McGraw, B G Rubin, B T Allen, C B Anderson, G A Sicard.   

Abstract

Seemingly minor blue-toe lesions resulting from atheroemboli are associated with unstable atherosclerotic plaques, which are at risk for causing recurrent emboli, tissue loss, and potentially death. At Washington University Medical Center, 62 patients (31 males and 31 females), ranging in age from 38 to 89 years (mean 62.8 +/- 11.7 years), were treated for cutaneous manifestations of atheroembolic disease. Most patients (62%) had spontaneous bouts of atheroembolism, but 13 (21%) had recently undergone an inciting invasive radiologic study, 10 (16%) were on anticoagulation therapy, and one (2%) experienced abdominal trauma. In addition to the cutaneous manifestations, 18 patients (29%) also developed coincidental deterioration in renal function and four (6%) had intestinal infarction from atheroemboli. Arteriography in nearly all patients (97%) implicated the aorta and iliac arteries most commonly (80%), with the femoral (13%), popliteal (3%), and subclavian (3%) arteries less frequently incriminated. Forty-two patients underwent bypass grafting procedures (36 anatomic and six extra-anatomic) after exclusion of the native diseased artery, 20 patients had endarterectomies (six with additional bypass grafts), and five patients had no corrective vascular procedures. The 30-day operative mortality rate was 5% in this series. Nineteen patients (31%) required minor amputations, whereas two required major leg amputations. Thus limb salvage was possible in 86 of 88 (98%) limbs. No further episodes of atheroembolism occurred in the involved limbs during follow-up (1 to 53 months, mean 20.2 months). We advocate urgent arteriography and surgical correction or bypass with exclusion of the offending lesion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8043359     DOI: 10.1007/BF02018173

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  6 in total

1.  Embolism from the Aorta: Atheroemboli and Thromboemboli.

Authors:  Paul A. Tunick; Itzhak Kronzon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

2.  Cholesterol crystal embolisation to the alimentary tract.

Authors:  W Moolenaar; C B Lamers
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

3.  Endovascular strategies for treatment of embolizing thoracoabdominal aortic lesions.

Authors:  Geetha Jeyabalan; Justin R Wallace; Rabih Antoine Chaer; Steven A Leers; Luke Keith Marone; Michel S Makaroun
Journal:  J Vasc Surg       Date:  2014-01-14       Impact factor: 4.268

Review 4.  Cholesterol embolisation after thrombolytic therapy.

Authors:  J C Blankenship
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

5.  Cholesterol crystal embolization following plaque rupture: a systemic disease with unusual features.

Authors:  Firas Ghanem; Deepthi Vodnala; Jagadeesh K Kalavakunta; Sridevi Durga; Noah Thormeier; Prem Subramaniyam; Scott Abela; George S Abela
Journal:  J Biomed Res       Date:  2017-01-19

6.  The prognosis of kidney transplant recipients with aorto-iliac calcification: a systematic review and meta-analysis.

Authors:  Elsaline Rijkse; Jacob L van Dam; Joke I Roodnat; Hendrikus J A N Kimenai; Jan N M IJzermans; Robert C Minnee
Journal:  Transpl Int       Date:  2020-03-04       Impact factor: 3.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.